Carregant...
Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy
Hepatocellular carcinoma (HCC), the most common primary liver cancer, is one of the dreaded complications of chronic liver disease. Recent experimental and clinical studies have revealed that the alteration of gut-liver axis plays a pivotal role in the onset of chronic liver diseases, including HCC....
Guardat en:
| Publicat a: | Hepatobiliary Surg Nutr |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5835615/ https://ncbi.nlm.nih.gov/pubmed/29531939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2017.12.07 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|